Evidence map›Paper›PMID 33732251›Full record

SynthesisFrontiers in immunology2021

SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.

Marton Olbei, Isabelle Hautefort, Dezso Modos, Agatha Treveil, Martina Poletti, Lejla Gul, Claire D Shannon-Lowe, Tamas Korcsmaros

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 112 citations in OpenAlex.

  1. InflawellInflammopharmacology · 2022
    Trial
  2. Immune Dysregulation After COVID-19: Longitudinal Analysis up to 9 Months.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marton OlbeiEarlham Institute, Norwich, United Kingdom.
Isabelle HautefortEarlham Institute, Norwich, United Kingdom.
Dezso ModosEarlham Institute, Norwich, United Kingdom.
Agatha TreveilEarlham Institute, Norwich, United Kingdom.
Martina PolettiEarlham Institute, Norwich, United Kingdom.
Lejla GulEarlham Institute, Norwich, United Kingdom.
Claire D Shannon-LoweInstitute of Immunology and Immunotherapy, The University of Birmingham, Birmingham, United Kingdom.
Tamas KorcsmarosEarlham Institute, Norwich, United Kingdom.
Earlham Institute · GBQuadram Institute · GBUniversity of Birmingham · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10355Medical Research Council MR/N023781/1
6 · The paper itself

Abstract

Hyper-induction of pro-inflammatory cytokines, also known as a cytokine storm or cytokine release syndrome (CRS), is one of the key aspects of the currently ongoing SARS-CoV-2 pandemic. This process occurs when a large number of innate and adaptive immune cells activate and start producing pro-inflammatory cytokines, establishing an exacerbated feedback loop of inflammation. It is one of the factors contributing to the mortality observed with coronavirus 2019 (COVID-19) for a subgroup of patients. CRS is not unique to the SARS-CoV-2 infection; it was prevalent in most of the major human coronavirus and influenza A subtype outbreaks of the past two decades (H5N1, SARS-CoV, MERS-CoV, and H7N9). With a comprehensive literature search, we collected changing the cytokine levels from patients upon infection with the viral pathogens mentioned above. We analyzed published patient data to highlight the conserved and unique cytokine responses caused by these viruses. Our curation indicates that the cytokine response induced by SARS-CoV-2 is different compared to other CRS-causing respiratory viruses, as SARS-CoV-2 does not always induce specific cytokines like other coronaviruses or influenza do, such as IL-2, IL-10, IL-4, or IL-5. Comparing the collated cytokine responses caused by the analyzed viruses highlights a SARS-CoV-2-specific dysregulation of the type-I interferon (IFN) response and its downstream cytokine signatures. The map of responses gathered in this study could help specialists identify interventions that alleviate CRS in different diseases and evaluate whether they could be used in the COVID-19 cases.

Indexed as

Severity of Illness IndexCOVID-19Cytokine Release SyndromeCytokinesHumansInflammationInfluenza A virusInfluenza, HumanMiddle East Respiratory Syndrome CoronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusCytokinescytokine responseinfluenza Aliterature analysisMERS- and SARS-CoVSARS-CoV-2systematic review

Identifiers

PMID33732251
PMCPMC7956943
OpenAlexW3134608058

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.